Please login to read the full article.
Scrip Regulatory Affairs
EU medtech regulators' group sticks to legally correct labelling decision, launches transparency initiative
02 November 2011
Amanda Maxwell
Please login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- Calls for delay of EU medtech labelling decision as concerns continue
- Australia revises medical device reform proposals; third-party assessments put on hold
- EU parliament resolution plan expected to call for device pre-market authorisation system
- EU medtech regulatory reform could involve unannounced notified body visits, greater transparency and tighter controls on Class III devices
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
